ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly.

Cristina Álvarez-Escolá,Eva María Venegas-Moreno,Juan Antonio García-Arnés,Concepción Blanco-Carrera, Mónica Marazuela-Azpiroz,María Ángeles Gálvez-Moreno,Edelmiro Menéndez-Torre, Javier Aller-Pardo,Isabel Salinas-Vert,Eugenia Resmini,Elena María Torres-Vela, María Ángeles Gonzalo-Redondo, Ricardo Vílchez-Joya, María Paz de Miguel-Novoa,Irene Halperín-Rabinovich, Concepción Páramo-Fernández, Guillermo de la Cruz-Sugranyes,Aude Houchard,Antonio Miguel Picó-Alfonso

Endocrinología, Diabetes y Nutrición (English ed.)（2019）

引用 7|浏览20

暂无评分

摘要

Real-life treatment with lanreotide Autogel resulted in early hormonal control in responding patients, with high treatment adherence and satisfaction despite disparity in starting doses and dosing intervals.

查看译文

关键词

Acromegaly,Lanreotide,Somatuline Autogel,Dosage regimens,Growth hormone (GH),Insulin-like growth factor (IGF-I)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要